Home > Journals > Minerva Endocrinology > Past Issues > Minerva Endocrinologica 2020 December;45(4) > Minerva Endocrinologica 2020 December;45(4):345-53



Publishing options
To subscribe
Submit an article
Recommend to your librarian


Publication history
Cite this article as


REVIEW   Free accessfree

Minerva Endocrinologica 2020 December;45(4):345-53

DOI: 10.23736/S0391-1977.20.03248-4


language: English

Endocrinological disorders and inflammatory skin diseases during COVID-19 outbreak: a review of the literature

Claudio MARASCA 1, Gabriella FABBROCINI 1, Luigi BARREA 2, Gianmarco CAPASSO 1 , Adriana DI GUIDA 1, Eleonora CINELLI 1, Giuseppina FONTANELLA 1

1 Section of Dermatology, Department of Clinical Medicine and Surgery, Federico II University Hospital, Naples, Italy; 2
Section of Endocrinology, Department of Clinical Medicine and Surgery, Federico II University Hospital, Naples, Italy

INTRODUCTION: In the next future, dermatologists, endocrinologist and physicians may cope with the impact of extent SARS-CoV-2 (COVID-19) infection over chronic inflammatory skin diseases and their treatment. COVID-19 pandemic obliged many countries to impose social restrictions, resulting in the need to adapt daily lifestyle habits and working activities. These changes have drastically reduced physical activity and social interactions, with the possible increase of anxiety, eating disorders and weight gain.
EVIDENCE ACQUISITION: We searched for relevant studies (trials, real-life studies and case reports, meta-analysis, pooled data analysis, reviews) on endocrine disorders and inflammatory skin diseases. The database used was PubMed. The studies included were those published in the English language between January 1, 2018 and May 5, 2020.
EVIDENCE SYNTHESIS: Several studies have been previously showed the association of overweight and obesity, with the metabolic syndrome and insulin-resistance. It has been demonstrated how these conditions correlate with the worsening of such chronic inflammatory skin diseases, such as psoriasis, hidradenitis suppurativa and acne. Many evidences suggest an important role of adipose tissue in the production of pro-inflammatory cytokines (Leptin, adiponectin, TNFα, IL-6, MCP-1, PAI-1), involved in the pathogenesis and the exacerbations of these skin diseases. In addition, we should expect an increasing incidence rate of hypovitaminosis D in the next future due to reduced sun exposure caused by isolation at home and missed holidays. Scientific evidences already show the important immunomodulating role of vitamin D in inflammatory skin diseases.
CONCLUSIONS: Our study pays attention on medium-long term effects of COVID-19 outbreak on inflammatory skin disorders, due to the lifestyle changes. In such context this review considers how a multidisciplinary approach, involving dermatologists, nutritionists and endocrinologists, may lead to a better management of dermatologic patients.

KEY WORDS: COVID-19; Skin; Endocrinology

top of page